The COVID-19 pandemic has triggered an unprecedented mobilization of resources to find vaccines and therapeutics to treat and prevent infection with SARS-CoV-2. mRNA technology was quickly adopted ...
GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory ... generation COVID-19 shot that is in phase 2 testing, along with a seasonal influenza candidate ...
The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine ... 19 and flu in a single jab in a phase 1/2 trial, while a triple shot that also adds in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback